FDA Approves New Breast Cancer Pill After Hormone Therapy Stops Working
The approach was found to shrink tumors in 27 percent of cases, compared to 14 percent of those using standard hormone therapy.
We haven't written up this one. Newsweek has the full story — the link below goes straight to it.